VIST Labs
Schaumburg, US · Founded 2020 · Delaware LLC
Find your way into VIST Labs
Sign up to see every warm intro you have to VIST Labs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VIST Labs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VIST Labs produces CryoPasteurization, a decontamination technology that removes harmful microbial contaminants from cannabis while preserving terpenes and cannabinoids for cultivators and producers. The pharmaceutical-grade process uses natural methods without chemicals or irradiation to help cannabis meet state testing standards.
Founders & leadership
RF

Roman ForowyczManager
JS
James SanfilippoManager
DB
Daniel BryantManager
RC

Rick CytrynbaumManager
JS
John SanfilippoManager
CH
Christian HagesethManagerChristian Hageseth is Co-Founder and COO of VIST Labs, a healthcare technology company providing decontamination and modified atmosphere packaging for cannabis. He previously founded Green Man Cannabis in Denver, Colorado, and American Cannabis Partners, and authored "Big Weed: An Entrepreneur's High Stakes Adventures in the Budding Legal Marijuana Industry."
Reported raises · per SEC filings
Form D private placements$6.2M disclosed across 1 round · 2021
▶$6.2MraisedMay 2023 · 28 investors · Other
▶$6.2MraisedMay 2023 · 28 investors · Other
Officers, directors & promoters on the filing
- Roman ForowyczDirector
- James SanfilippoDirector
- Daniel BryantDirector
- Rick CytrynbaumDirector
- John SanfilippoDirector
- Christian HagesethDirector
- Offering amount
- $6.2M
- Amount sold
- $6.2M
- First sale
- Jan 2021
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Candid TherapeuticsCandidRx develops T-cell engager antibodies to treat autoimmune diseases by redirecting T-cells to eliminate autoreactive B-cells. The company focuses on creating therapies that are more effective and easier to administer than existing antibody and cell therapy approaches.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Companies working in the same space as VIST Labs.
Frequently asked questions
- What does VIST Labs do?
- VIST Labs produces CryoPasteurization, a decontamination technology that removes harmful microbial contaminants from cannabis while preserving terpenes and cannabinoids for cultivators and producers. The pharmaceutical-grade process uses natural methods without chemicals or irradiation to help cannabis meet state testing standards.
- How much funding has VIST Labs raised?
- VIST Labs has disclosed $6.2M raised across 1 round.
- Where is VIST Labs headquartered?
- VIST Labs is headquartered in Schaumburg, US.
